BOT 6.15% 34.5¢ botanix pharmaceuticals ltd

Ann: Canine Atopic Dermatitis Program Launched, page-7

  1. 120 Posts.
    lightbulb Created with Sketch. 20
    you wouldn't expect a study on a few dogs to set the world on fire. It is a step forward in the right direction and hearing that the Rosacea study is progressing as planned is more significant for me.
    Both studies wil provide essential data and help ensure that phase 3 studies in particular acne will hit the best formulation to provide optimal results.
    I am content with progress but suspect the sp will continue to linger until we hear that recruitment for rosacea is finalised and there are only a few weks to go before results for that study come out.
    i am happy to be holding and think it wont be that much longer before the accumulation phase ends
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
34.5¢
Change
0.020(6.15%)
Mkt cap ! $624.4M
Open High Low Value Volume
32.5¢ 34.5¢ 32.5¢ $2.676M 7.955M

Buyers (Bids)

No. Vol. Price($)
2 19000 34.0¢
 

Sellers (Offers)

Price($) Vol. No.
34.5¢ 48210 1
View Market Depth
Last trade - 16.10pm 03/07/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.